Literature DB >> 3110275

Absence of somatic mutation in the variable region of MPC 11 variants expressing a different heavy chain isotype.

G L Gilmore, J Q Yang, K B Marcu, B K Birshtein.   

Abstract

Somatic mutation of immunoglobulin variable regions contributes to the diversity of the immune response. Some investigators have postulated that somatic mutation is coupled to isotype switching; others have presented evidence that the two processes are not linked. By using in vitro variants of the MPC 11 mouse myeloma cell line that produce heavy chains of different isotypes, we have examined several VH regions at the nucleotide level using a variety of different sequencing procedures. We have found no evidence of somatic mutation and conclude that the processes of somatic mutation and isotype switching may be independent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110275

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.

Authors:  A Matolcsy; P Casali; R G Nádor; Y F Liu; D M Knowles
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

2.  Mitotic recombination is responsible for the loss of heterozygosity in cultured murine cell lines.

Authors:  F K Nelson; W Frankel; T V Rajan
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.

Authors:  Xiaodi Ren; Rachael Siegel; Unkyu Kim; Robert G Roeder
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

4.  Sites that direct nuclear compartmentalization are near the 5' end of the mouse immunoglobulin heavy-chain locus.

Authors:  Qiaoxin Yang; Roy Riblet; Carl L Schildkraut
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus.

Authors:  R Clynes; J Wax; L W Stanton; S Smith-Gill; M Potter; K B Marcu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.